Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and Beyond
AUTOR(ES)
Zeki, Amir A.
FONTE
American Thoracic Society
RESUMO
Rationale: Statin use has been linked to improved lung health in asthma and chronic obstructive pulmonary disease. We hypothesize that statins inhibit allergic airway inflammation and reduce airway hyperreactivity via a mevalonate-dependent mechanism.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2778150Documentos Relacionados
- Sympathomimetics and airway hyperreactivity.
- Chemokines and their role in airway hyper-reactivity
- Exercise-induced bronchoconstriction as an expression of bronchial hyperreactivity: a study of its mechanisms in children.
- Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions.
- A Gene Cluster for the Mevalonate Pathway from Streptomyces sp. Strain CL190
